Registration - Consultant

Therapure Biopharma Inc. / Therapure Biopharma Inc. / JEFF SMITH, Consultant

Registration Information

Client name: Therapure Biopharma Inc. / Therapure Biopharma Inc.
Lobbyist name: JEFF SMITH, Consultant
Initial registration start date: 2016-12-02
Registration status: Inactive
Registration Number: 776310-359004

Associated Communications

Total Number of Communication Reports: 9

Monthly communication reports in the last 6 months: 0

Version 2 of 4 (2017-05-24 to 2017-08-08)

Registration versions:

Version 2 of 4 (2017-05-24 to 2017-08-08)

Lobbying Information

Subject Matters

Economic Development
Research and Development
Science and Technology

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Therapure Biopharma Inc is seeking federal financial assistance for the commercialization of its patented plasma technology.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Finance Canada (FIN)
Innovation, Science and Economic Development Canada (ISED)
Prime Minister's Office (PMO)

Client Details

Government funding

End date of the last completed financial year: 2016-12-31

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
National Research Council (NRC)	$46,989.00	Yes

Client Contact Information

Address:
2585 Meadowpine Blvd.
Mississauga, ON L5N 8H9
Canada

Telephone number: 905-286-6256
Fax number: 905-286-6300

Client representative

Mark Krause, Head of Plasma Proteins

Parent Company Information

Therapure Biopharma Inc. / Therapure Biopharma Inc. is not a subsidiary of any other parent companies.

Coalition Members Information

Therapure Biopharma Inc. / Therapure Biopharma Inc. is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Therapure Biopharma Inc. / Therapure Biopharma Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Therapure Biopharma Inc. / Therapure Biopharma Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

JEFF SMITH | Public offices held

Business address:
150 Eastbourne Avenue
Toronto, ON M5P 2G6
Canada

Telephone number: 416-457-4571

Consultant Firm and Address

Firm: Drysdale Forstner Hamilton Public Affairs

Address:
55 University Avenue
Suite 1105
Toronto, ON M5J 2H7
Canada

Telephone number: 416-457-4571

Therapure Biopharma Inc./Therapure Biopharma Inc.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Therapure Biopharma Inc./Therapure Biopharma Inc.	2016-12-02	2018-05-01

Therapure Biopharma Inc. / Therapure Biopharma Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

JEFF SMITH, Longview Communications and Public Affairs (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-9 of 9

Therapure Biopharma Inc.
Consultant: JEFF SMITH

Designated Public Office Holders who participated in the communication:
- David McFarlane, Director of Policy | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development
Communication date: 2018-04-06
Posted date: 2018-05-15
Communication number: 359004-423167 View associated registration
Therapure Biopharma Inc.
Consultant: JEFF SMITH

Designated Public Office Holders who participated in the communication:
- David McFarlane, Director of Policy | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development
Communication date: 2018-04-03
Posted date: 2018-05-15
Communication number: 359004-423166 View associated registration
Therapure Biopharma Inc.
Consultant: JEFF SMITH

Designated Public Office Holders who participated in the communication:
- Javid Dharas, Policy Advisor | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development
Communication date: 2018-02-06
Posted date: 2018-03-15
Communication number: 359004-418836 View associated registration
Therapure Biopharma Inc.
Consultant: JEFF SMITH

Designated Public Office Holders who participated in the communication:
- David McFarlane, Director of Policy | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
- Javid Dharas, Policy Advisor | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development
Communication date: 2018-01-10
Posted date: 2018-02-15
Communication number: 359004-418329 View associated registration
Therapure Biopharma Inc.
Consultant: JEFF SMITH

Designated Public Office Holders who participated in the communication:
- David McFarlane, Director of Policy | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development
Communication date: 2017-12-06
Posted date: 2018-01-15
Communication number: 359004-414893 View associated registration
Therapure Biopharma Inc.
Consultant: JEFF SMITH

Designated Public Office Holders who participated in the communication:
- Mitch Davies, Assistant Deputy Minister | Innovation Canada | Innovation, Science and Economic Development Canada (ISED)
- Colette Kaminsky, Executive Director, Strategic Innovation Fund | Innovation Canada | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development
Communication date: 2017-10-24
Posted date: 2017-11-15
Communication number: 359004-410836 View associated registration
Therapure Biopharma Inc.
Consultant: JEFF SMITH

Designated Public Office Holders who participated in the communication:
- David McFarlane, Director of Policy | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Research and Development, Science and Technology
Communication date: 2017-06-14
Posted date: 2017-06-15
Communication number: 359004-403965 View associated registration
Therapure Biopharma Inc.
Consultant: JEFF SMITH

Designated Public Office Holders who participated in the communication:
- David McFarlane, Director of Policy | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Science and Technology
Communication date: 2016-12-19
Posted date: 2016-12-20
Communication number: 359004-391856 View associated registration
Therapure Biopharma Inc.
Consultant: JEFF SMITH

Designated Public Office Holders who participated in the communication:
- Daniel Grubb, Special Assistant, Regional Development | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development
Communication date: 2016-12-13
Posted date: 2016-12-20
Communication number: 359004-391855 View associated registration

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Legislative Assistant to the Deputy Prime Minister and Minister of the Environment Office of the Deputy Prime Minister, Minister's Office	October 1993 to February 1995	Not a designated office
Special Assistant Office of the Deputy Leader of the Opposition, Deputy Leader's Office	October 1990 to October 1993	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Legislative Assistant to the Deputy Prime Minister and Minister of the Environment Office of the Deputy Prime Minister, Minister's Office	October 1993 to February 1995	Not a designated office
Special Assistant Office of the Deputy Leader of the Opposition, Deputy Leader's Office	October 1990 to October 1993	Not a designated office

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Therapure Biopharma Inc. / Therapure Biopharma Inc. / JEFF SMITH, Consultant

Registration Information

Associated Communications

Version 2 of 4 (2017-05-24 to 2017-08-08)

Version 2 of 4 (2017-05-24 to 2017-08-08)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address